Mark L. Baum

Insider Reports History

Entity: Individual
Location: C/O Imprimis Pharmaceuticals, Inc, 12264 El Camino Real, Suite 350, San Diego, CA
Signature: /s/ Mark L. Baum
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark L. Baum:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
HARROW, INC.	Chief Executive Officer, Director, 10%+ Owner	Common Stock	2.6M	$60M	$23.09	Apr 7, 2025	Direct
HARROW, INC.	Chief Executive Officer, Director, 10%+ Owner	Performance Stock Unit	0	$0	$30.01	Apr 3, 2025	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by Mark L. Baum

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
HROW	HARROW, INC.	Apr 3, 2025	3	-$6.94M	4	Apr 7, 2025	Chief Executive Officer, Director, 10%+ Owner
HROW	HARROW, INC.	Mar 22, 2024	1	$104K	4	Mar 25, 2024	CHIEF EXECUTIVE OFFICER, Director
HROW	HARROW, INC.	Feb 20, 2024	3	$962K	4	Feb 21, 2024	CHIEF EXECUTIVE OFFICER, Director
HROW	HARROW, INC.	Feb 7, 2024	2	$119K	4	Feb 8, 2024	CHIEF EXECUTIVE OFFICER, Director
HROW	HARROW, INC.	Nov 16, 2023	1	$60.8K	4	Nov 16, 2023	Chief Executive Officer, Director
HROW	HARROW HEALTH, INC.	Aug 14, 2023	1	$98.9K	4	Aug 15, 2023	Chief Executive Officer, Director
HROW	HARROW HEALTH, INC.	Jul 18, 2023	3	-$5.47M	4	Jul 20, 2023	Chief Executive Officer, Director
HROW	HARROW HEALTH, INC.	Apr 3, 2023	4	-$849K	4	Apr 4, 2023	Chief Executive Officer, Director
HROW	HARROW HEALTH, INC.	Jan 2, 2023	3	-$519K	4	Jan 3, 2023	Chief Executive Officer, Director
HROW	HARROW HEALTH, INC.	Dec 22, 2022	1	$335K	4	Dec 23, 2022	Chief Executive Officer, Director
HROW	HARROW HEALTH, INC.	Jan 20, 2022	3	-$295K	4	Jan 21, 2022	Chief Executive Officer, Director
HROW	HARROW HEALTH, INC.	Jul 23, 2021	1	$0	4	Jul 23, 2021	Chief Executive Officer, Director